A Department of Health and Human Services draft federal policy said that 6 unapproved peptides could soon be sold by compounding pharmacies.

Patients with autoimmune inflammatory rheumatic diseases (AIRDs) have a significantly higher risk of developing Long COVID after SARS-CoV-2 infection than patients without AIRDs, according to results ...

SGLT2 inhibitors significantly reduced mortality and lowered risks for cardiovascular and kidney events in CKD patients 80 years and older.

Among adults aged 18 to 64 years old, living alone was associated with an increased risk for death from multiple causes.

HealthDay News — The combination of estrogen and testosterone therapy (E+T) may improve bone mineral density (BMD) outcomes in postmenopausal women more than estrogen alone, according to a study ...

Reducing doses of biologic and targeted synthetic DMARDs effectively maintains low disease activity in patients with rheumatoid arthritis.

Obesity and increasing BMI are associated with an increased risk for primary biologic failure among patients with psoriasis, but are not significantly associated with secondary fa ...

High-volume injections with or without corticosteroids did not improve pain or disability in adults with midportion Achilles tendinopathy.

Deucravacitinib treatment yields sustained improvements in joint symptoms and skin disease severity among patients with active psoriatic arthritis.

Psoriasis was associated with increased risks for cataract and cataract surgery, with the risks varying by treatment modality.

Digital physical activity programs for inflammatory arthritis are linked to slight pain reductions but worsening functional disability.

Patients with interstitial lung disease and an underlying autoimmune condition demonstrate a lower mortality risk than those with idiopathic disease.